Therapeutic and legal aspects of psilocybin in cancer-related depression
Frontiers in Psychiatry August 4, 2025 Wierzbicka Małgorzata, Renata Kopczyk, Alexander L. Gerlach et al. 1 citation
Depression prevalence is markedly elevated in oncological patients, particularly among head and neck cancer (HNC) cohorts, who face twice the prevalence of major depressive disorder (MDD) compared to other cancer populations. MDD in this context independently predicts poorer clinical outcomes and increased morbidity. HNC management often involves acute surgical interventions with disfiguring...